全文获取类型
收费全文 | 78267篇 |
免费 | 7238篇 |
国内免费 | 46篇 |
出版年
2021年 | 949篇 |
2020年 | 570篇 |
2019年 | 759篇 |
2018年 | 945篇 |
2017年 | 845篇 |
2016年 | 1544篇 |
2015年 | 2548篇 |
2014年 | 2936篇 |
2013年 | 3894篇 |
2012年 | 4966篇 |
2011年 | 4948篇 |
2010年 | 3245篇 |
2009年 | 2993篇 |
2008年 | 4293篇 |
2007年 | 4524篇 |
2006年 | 4244篇 |
2005年 | 4073篇 |
2004年 | 4092篇 |
2003年 | 3930篇 |
2002年 | 3680篇 |
2001年 | 865篇 |
2000年 | 660篇 |
1999年 | 950篇 |
1998年 | 1092篇 |
1997年 | 793篇 |
1996年 | 741篇 |
1995年 | 704篇 |
1994年 | 677篇 |
1993年 | 718篇 |
1992年 | 716篇 |
1991年 | 643篇 |
1990年 | 606篇 |
1989年 | 588篇 |
1988年 | 596篇 |
1987年 | 594篇 |
1986年 | 587篇 |
1985年 | 651篇 |
1984年 | 784篇 |
1983年 | 696篇 |
1982年 | 818篇 |
1981年 | 874篇 |
1980年 | 831篇 |
1979年 | 558篇 |
1978年 | 587篇 |
1977年 | 572篇 |
1976年 | 497篇 |
1975年 | 459篇 |
1974年 | 539篇 |
1973年 | 465篇 |
1972年 | 322篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
4.
5.
Wendy A. Douglass Robert H. Hyland Christopher D. Buckley Aymen Al-Shamkhani Jacqueline M. Shaw Sarah L. Scarth David L. Simmons S.K.Alex Law 《FEBS letters》1998,440(3):125
The cysteine-rich region (CRR) of the β2 integrin subunit was replaced by that of β1 to give the chimera β2NV1. β2NV1 can combine with αL to form a variant leukocyte-function-associated antigen (LFA)-1 on COS cell surface, suggesting that the specificity of the β2 interaction with αL does not lie in the CRR. Unlike those expressing wild-type LFA-1, COS cells expressing αLβ2NV1 are constitutively active in intercellular adhesion molecule (ICAM)-1 adhesion. These results suggest that activation of LFA-1 involves the release of an intramolecular constraint, which is maintained, in part, by the authentic β2 CRR. 相似文献
6.
Grape thaumatin-like proteins (TLPs) play roles in plant-pathogen interactions and can cause protein haze in white wine unless removed prior to bottling. Different isoforms of TLPs have different hazing potential and aggregation behavior. Here we present the elucidation of the molecular structures of three grape TLPs that display different hazing potential. The three TLPs have very similar structures despite belonging to two different classes (F2/4JRU is a thaumatin-like protein while I/4L5H and H2/4MBT are VVTL1), and having different unfolding temperatures (56 vs. 62°C), with protein F2/4JRU being heat unstable and forming haze, while I/4L5H does not. These differences in properties are attributable to the conformation of a single loop and the amino acid composition of its flanking regions. 相似文献
7.
Robert S. Steneck 《Current biology : CB》2009,19(3):R117-R119
8.
9.
10.
An perfusion system was used to assess the effects of chloride channel blockers, dopamine (DA) receptor agonists and antagonists, and GABA receptor agonists and antagonists on prolactin release from the mouse anterior pituitary. Dopamine and muscimol inhibited prolactin release ( respectively). The GABA receptor antagonist bicuculline blocked the inhibition of prolactin release by muscimol but not dopamine. The dopamine receptor antagonist chlorpromazine blocked the dopamine- but not muscimol-induced inhibition of prolactin release. Haloperidol, however, reversed both the muscimol and dopamine induced inhibition of prolactin release. Furthermore, the chloride channel blocker picrotoxinin blocked the inhibition of prolactin release elicited by both dopamine and muscimol. These later results suggest that the anterior pituitary dopamine receptor which mediates the inhibition of prolactin release may be coupled to a picrotoxinin sensitive chloride ionophore and that haloperidol may affect the function of both DA and GABA receptors in the anterior pituitary. 相似文献